Vikas Khemani-backed Q-Line Biotech opened its IPO on Wednesday, looking to raise up to Rs 214.48 crore through the NSE Emerge platform. The IPO consists of 62.53 lakh equity shares with a price band of Rs 326-343 per share. The company is commanding one of the strongest GMPs in recent past at 42% over the issue price.
The issue has been subscribed over 2 times on the first day, led by institutional investors and retail investors. The QIB portion was booked over 3 times, while the retail quota was subscribed just over 2 times.